Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Treasury Shares (2016 - 2023)

Historic Treasury Shares for Alaunos Therapeutics (TCRT) over the last 13 years, with Q3 2023 value amounting to $437500.0.

  • Alaunos Therapeutics' Treasury Shares rose 223333.33% to $437500.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $437500.0, marking a year-over-year increase of 223333.33%. This contributed to the annual value of $62604.0 for FY2022, which is 2165.2% down from last year.
  • Alaunos Therapeutics' Treasury Shares amounted to $437500.0 in Q3 2023, which was up 223333.33% from $657187.0 recorded in Q2 2023.
  • In the past 5 years, Alaunos Therapeutics' Treasury Shares registered a high of $1.6 million during Q3 2019, and its lowest value of $18750.0 during Q3 2022.
  • Moreover, its 5-year median value for Treasury Shares was $946002.0 (2022), whereas its average is $822695.6.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 9875.88% in 2022, then skyrocketed by 223333.33% in 2023.
  • Quarter analysis of 5 years shows Alaunos Therapeutics' Treasury Shares stood at $1.6 million in 2019, then plummeted by 49.91% to $786280.0 in 2020, then crashed by 89.84% to $79905.0 in 2021, then dropped by 21.65% to $62604.0 in 2022, then skyrocketed by 598.84% to $437500.0 in 2023.
  • Its Treasury Shares stands at $437500.0 for Q3 2023, versus $657187.0 for Q2 2023 and $898125.0 for Q1 2023.